Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000435759 | SCV000534584 | likely benign | not specified | 2018-02-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
| Labcorp Genetics |
RCV000558268 | SCV000622509 | likely benign | Ataxia-telangiectasia syndrome | 2024-09-10 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV001022619 | SCV001184377 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Color Diagnostics, |
RCV001022619 | SCV001735490 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-23 | criteria provided, single submitter | clinical testing | |
| Myriad Genetics, |
RCV004591267 | SCV005082961 | benign | Familial cancer of breast | 2024-05-20 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |